Comment on Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll

Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll

About half of adults with insurance said they had trouble paying for weight loss drugs, according to a new survey, which are currently not covered by Medicare. GLP-1 drugs such as Novo Nordisk’s Ozempic and Wegovy, and Eli Lilly’s Mounjaro—which are used to treat diabetes and heart disease—are having a moment in the sun as treatments for weight loss.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News